Increasing brain glucose uptake by Gypenoside <scp>LXXV</scp> ameliorates cognitive deficits in a mouse model of diabetic Alzheimer's disease-Reference-Cited by-同舟云学术

Increasing brain glucose uptake by Gypenoside LXXV ameliorates cognitive deficits in a mouse model of diabetic Alzheimer's disease

Published:2022-11-03 Issue:2 Volume:37 Page:611-626
ISSN:0951-418X
Container-title:Phytotherapy Research
language:en
Short-container-title:Phytotherapy Research

Author:

Meng Xiangbao¹²^ORCID,Zhang Yuan²,Li Zongyang²,Ma Guoxu³,Zhang Xiejun²,Zhang Di²,Cao Weiwei²,Wang Sicen⁴^ORCID,Cai Qian¹,Cui Ping⁵,Huang Guodong²

Affiliation:

1. College of Pharmacy Jinan University Guangzhou China

2. Department of Neurosurgery, Shenzhen Key Laboratory of Neurosurgery, Shenzhen Institute of Translational Medicine The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital Shenzhen China

3. Institute of Medicinal Plant Development Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

4. School of Medicine Xi'an Jiaotong University Xi'an China

5. Department of Pharmacy Shenzhen Children's Hospital Shenzhen China

Funder

China Postdoctoral Science Foundation

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ptr.7639

Reference46 articles.

1. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums

2. Diabetes and Alzheimer’s disease crosstalk

3. Microtubules in insulin action: what’s on the tube?

4. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications

5. Understanding multifactorial brain changes in type 2 diabetes: a biomarker perspective

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroprotective effects of Gypenosides: A review on preclinical studies in neuropsychiatric disorders;European Journal of Pharmacology;2024-09

2. Gypenoside inhibits gastric cancer proliferation by suppressing glycolysis via the Hippo pathway;Scientific Reports;2024-08-16

3. Herbal medicines in Alzheimer’s disease and the involvement of gut microbiota;Frontiers in Pharmacology;2024-07-16

4. Notoginsenoside R1, a novel natural PPARγ agonist, attenuates cognitive deficits in a mouse model of diabetic Alzheimer’s disease through enhancing GLUT4-dependent neuronal glucose uptake;2024-07-12

5. Esketamine induces tripartite motif-containing protein 24 to improve cognitive dysfunction in Alzheimer’s disease;Neuroscience Letters;2024-06